文献速递肿瘤 PET/CT核素与放射性配体治疗

FDG PET/CT引导下肝脏肿瘤热消融术中消融边缘评估的回顾性研究

Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2021-02-09

该回顾性研究纳入56例患者共77个FDG高摄取肝肿瘤,在FDG PET/CT引导下微波或冷冻消融术中利用单次屏气PET/CT评估消融边缘,并将最小消融边缘与局部进展关联。术中PET/CT评估可行率≥95%(73/77),高于术后MRI的≤63%(35/56);在61个可评估肿瘤中,最小消融边缘<5 mm者局部进展风险增加约6倍(HR 6.05,P=0.004)。

要点

  • 术中屏气PET/CT可可靠评估FDG高摄取肝肿瘤热消融的整个消融边缘。
  • 术中PET/CT评估消融边缘的可行率≥95%,高于术后MRI的≤63%。
  • 最小消融边缘<5 mm与局部肿瘤进展风险增加约6倍相关(HR 6.05,P=0.004)。

核心结论

  • FDG PET/CT引导热消融术中屏气PET/CT可可靠评估FDG高摄取肝肿瘤的整个消融边缘。
  • 最小PET/CT消融边缘阈值5 mm与局部肿瘤进展结局良好相关。

研究设计与样本

  • 回顾性研究纳入56例患者(年龄36至85岁,中位62岁;32例女性)共77个FDG高摄取肝肿瘤,接受60次FDG PET/CT引导经皮微波或冷冻消融。
  • 利用术中单次屏气PET/CT评估消融边缘:消融后肝肿瘤在PET上仍可见,微波消融区在增强CT上可见,冷冻消融区(冰球)在平扫CT上可见。
  • 两名读者回顾性判断消融边缘可评估性并测量术中PET/CT(n=77)与术后MRI(n=56)的最小消融边缘。
  • 对所有可用随访影像(1至49个月,平均15个月)评估局部肿瘤进展,并使用聚类生存模型对61个肿瘤分析PET/CT最小消融边缘与局部进展的相关性。

主要发现

  • 术中PET/CT评估最小消融边缘的可行率≥73/77(95%),高于术后MRI的≤35/56(63%)。
  • 在61个PET/CT可评估边缘的肿瘤中(排除PET/CT后重叠消融的肿瘤),最小消融边缘<5 mm者局部肿瘤进展风险增加6倍(HR 6.05;P=0.004)。

关键数值与推荐

  • 术中PET/CT最小消融边缘<5 mm对应的局部肿瘤进展风险比为6.05(P=0.004),基于61个PET/CT可评估边缘的肿瘤。
  • 术中PET/CT评估最小消融边缘可评估肿瘤数≥73/77(95%),术后MRI≤35/56(63%)。

临床怎么用

  • 在FDG PET/CT引导下对FDG高摄取肝肿瘤行微波或冷冻消融时,可利用术中屏气PET/CT评估消融边缘。
  • 术中PET/CT测得最小消融边缘<5 mm提示局部进展风险增高,可据此考虑追加消融或加强随访。

局限性

  • 本研究为回顾性设计。
  • 局部进展相关性分析仅纳入61个PET/CT可评估边缘的肿瘤,排除了PET/CT后重叠消融的肿瘤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To retrospectively assess liver tumor ablation margins using intraprocedural PET/CT images from FDG PET/CT-guided microwave or cryoablation procedures and to correlate minimum margin measurements with local progression outcomes. METHODS: Fifty-six patients (ages 36 to 85, median 62; 32 females) with 77 FDG-avid liver tumors underwent 60 FDG PET/CT guided, percutaneous microwave, or cryoablation procedures. Single breath-hold PET/CT images were used for intraprocedural assessment of the tumor ablation margin: liver tumors remained visible on PET immediately following ablation; microwave ablation zones were visible using contrast-enhanced CT; cryoablation zones (ice balls) were visible using unenhanced CT. Two readers retrospectively determined ablation margin assessability and measured the minimum ablation margin on intraprocedural PET/CT (n = 77) and postprocedural MRI (n = 56). Local tumor progression was assessed on all available follow-up imaging (1-49 months, mean 15). Local tumor progression was correlated with PET/CT minimum margin measurements using clustered survival models for 61 tumors. RESULTS: Minimum ablation margins were more often assessable using intraprocedural PET/CT (≥ 73/77 tumors, 95%) than postprocedural MRI (≤ 35/56 tumors, 63%). In 61 tumors with PET/CT-assessable margins (excluding tumors with overlapping ablations after PET/CT), there was a 6-fold increased risk of local tumor progression [hazard ratio (HR) 6.05; P = 0.004] for minimum ablation margins < 5 mm. CONCLUSION: Breath-hold PET/CT scans, during PET/CT-guided microwave or cryoablation procedures for FDG-avid liver tumors, enable reliable intraprocedural assessment of the entire tumor ablation margin; a minimum PET/CT ablation margin threshold of 5 mm correlates well with local tumor progression outcomes.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Casadaban LC, Catalano PJ, Lee LK, et al. Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study. Eur J Nucl Med Mol Imaging. 2021. PMID: 33559712. doi:10.1007/s00259-021-05206-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。